Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07851818

Screening Psychosocial Distress in Head and Neck Cancer

Sponsor: Hôpital NOVO

View on ClinicalTrials.gov

Summary

This prospective, multicenter study aims to assess the presence of psychosocial distress using the Distress Thermometer in patients treated for head and neck cancer at the initiation of their speech-language therapy. It also seeks to evaluate the evolution of this distress over a two-month period, as well as its correlation with patient engagement in therapy, functional disorders, and overall quality of life (assessed using the EORTC QLQ-C30 and QLQ-HN35 questionnaires). By capturing longitudinal changes in distress levels, functional impairments, and patient commitment to therapy, this research seeks to clarify the SLP's role in comprehensive supportive oncology care and optimize timely psychological referrals for vulnerable patients. The study hypothesizes that a significant proportion of patients experience clinically meaningful psychosocial distress (score ≥ 4 on the Distress Thermometer) at the start of speech-language therapy. It is also expected that this distress correlates with lower therapeutic engagement and impaired quality of life, and that early screening by speech-language pathologists will improve the timely referral of patients to psychological support professionals.

Official title: Psychosocial Distress Screening in Patients Treated for Head and Neck Cancer : The Value of Screening in Speech-Language Therapy Practice

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2026-11-30

Completion Date

2028-01-30

Last Updated

2026-10-01

Healthy Volunteers

No

Interventions

OTHER

Psychosocial distress screening using the Distress Thermometer

Administration of the Distress Thermometer and its accompanying Problem List to patients at the initiation of speech-language therapy to identify clinically significant psychosocial distress (score ≥ 4).